4.0
27 Apr 2023
Current employee, less than 1 year
Recommend
CEO approval
Business outlook
Pros
Small size lends more interactions with partners/associate partners, client, work ownership; diverse clients within healthcare sector (pharmas, biotechs, medtechs, CROs, and PE interested in healthcare); office location
Cons
Little margin to choose projects, significant proposal and due diligence projects depending on the season, lack of official trainings (although may improve with merger)